ORENCIA 125 mg solution for injection in pre-filled pen

Plasma cell depletion as an approach to reset autoimmunity in rheumatoid arthritis

A prospective, randomized, controlled, open label, assessor-blinded, parallel-group Phase III clinical trial to evaluate the impact of tapering systemic immunosuppressive therapy in a treat-to-target approach on maintaining minimal disease activity in adult subjects with psoriatic arthritis